Table 5.
Logistic regression analysis of variables associated with ATDH
| Variables | p value | COR(95% IC) | p value | AOR (95% IC) |
|---|---|---|---|---|
| Age > 35 years | 0.23 | 1.59 (0.73-3.45) | - | - |
| Female sex | 0.17 | 0.58 (0.27-1.26) | 0.33 | 0.64(0.26-1.57) |
| Smoking status | 0.63 | 0.82 (0.38-1.79) | - | - |
| Alcohol consumption | 0.76 | 1.22 (0.32-4.65) | - | - |
| Cannabis consumption | 0.12 | 5.11 (0.64-40.41) | 0.28 | 3.28(0.37-28.73) |
| HIV coinfection | 0.10 | 0.35 (0.10-1.25) | 0.93 | 0.93(0.18-4.68) |
| Malnutrition | 0.51 | 1.32 (0.57-3.044) | - | - |
| Renal failure | 0.68 | 0.74 (0.18-3.05) | - | - |
| Pulmonary form | 0.12 | 3.83 (0.14-4.78) | 0.50 | 1.94(0.27-13.71) |
| Hepatitis B coinfection | 0.42 | 0.47 (0.07-2.97) | - | - |
| Combined form of drugs | 0.002 | 13.12 (2.58-66.70) | 0.003 | 13.53(2.37-77.07) |
| Plasma concentration of isoniazid > 2 mg / l | 0.045 | 1.29 (1.01-1.67) | 0.04 | 1.45(1.18-3.11) |
| Plasma concentration of rifampicin>24 mg / l | 0.99 | - | - | - |
| Plasma concentration of pyrazinamid > 50 mg / l | 0.28 | 0.95 (0.87-1.03) | - | - |